2012
DOI: 10.1155/2012/984950
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of Hypoxia-Induced Cell Death in Human Tenocytes

Abstract: Degenerate shoulder tendons display evidence of hypoxia. However tendons are relatively avascular and not considered to have high oxygen requirements and the vulnerability of tendon cells to hypoxia is unclear. Cultured human tenocytes were exposed to hypoxia and the cellular response detected using QPCR, Western blotting, viability, and ELISA assays. We find that tenocytes respond to hypoxia in vitro by activating classical HIF-1α-driven pathways. Total hypoxia caused significant tenocyte apoptosis. Transcrip… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
28
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(28 citation statements)
references
References 37 publications
0
28
0
Order By: Relevance
“…8,9 Furthermore, various genetically controlled biological mechanisms have been recognized to contribute to rotator cuff disease and similar tendinopathies, including apoptosis and factors that influence the regulation of the extracellular matrix. [12][13][14][15][16]30 Motta et al 20 recently tested 23 single nucleotide polymorphisms (SNPs) from 6 candidate genes involved in the repair and degenerative processes of musculoskeletal tissue (DEFB1, DENND2C, ESRRB, FGF3, FGF10, and FGFR1) for a potential association with rotator cuff disease. The authors identified 1 significant SNP after correcting for multiple testing (Bonferroni correction threshold is P < .05/23 ¼ .002).…”
mentioning
confidence: 99%
“…8,9 Furthermore, various genetically controlled biological mechanisms have been recognized to contribute to rotator cuff disease and similar tendinopathies, including apoptosis and factors that influence the regulation of the extracellular matrix. [12][13][14][15][16]30 Motta et al 20 recently tested 23 single nucleotide polymorphisms (SNPs) from 6 candidate genes involved in the repair and degenerative processes of musculoskeletal tissue (DEFB1, DENND2C, ESRRB, FGF3, FGF10, and FGFR1) for a potential association with rotator cuff disease. The authors identified 1 significant SNP after correcting for multiple testing (Bonferroni correction threshold is P < .05/23 ¼ .002).…”
mentioning
confidence: 99%
“…Indeed, a higher VA could be essential to support a highly plastic tissue having a very high synthetic activity especially in fetal tendons. Nevertheless, a role for VEGF in sustaining protection and survival of tendon cells in line with the effects recently reported in human tenocytes (Liang et al 2012) and chondrocytes (Maes et al 2012) should not be excluded. Healthy human tenocytes express several VEGF isoforms (Liang et al 2012), and VEGFA mRNA is strongly upregulated following hypoxia under both low-and high-serum conditions.…”
Section: In Humans Probably the Low Pi In Adult Tendons Ismentioning
confidence: 96%
“…Nevertheless, a role for VEGF in sustaining protection and survival of tendon cells in line with the effects recently reported in human tenocytes (Liang et al 2012) and chondrocytes (Maes et al 2012) should not be excluded. Healthy human tenocytes express several VEGF isoforms (Liang et al 2012), and VEGFA mRNA is strongly upregulated following hypoxia under both low-and high-serum conditions. Additionally, VEGF protein released in culture medium increased fourfold by anoxia, exercising a rescue role from cell death (Liang et al 2012).…”
Section: In Humans Probably the Low Pi In Adult Tendons Ismentioning
confidence: 96%
See 1 more Smart Citation
“…Although this gene is a marker of chondrogenic differentiation, it is known that its expression is also upregulated in tenocytic cells with increased expression of scleraxis . 7 , 16 For chondorogenic differentiation, reoxygenated cells were seeded at concentration of 1×10 6 cells into a 15-mL tube, and cell pellets were cultured in chondrogenic-induction medium (Cat No. PT-3003) supplemented with transforming growth factor β3 (10 ng/mL) (Lonza) for 4 weeks.…”
Section: Methodsmentioning
confidence: 99%